Andere Sprachen AroCell AB

Aktien

Markt geschlossen - Nasdaq Stockholm Andere Börsenplätze 11:20:49 30.04.2024			% 5 Tage	% 1. Jan.
0,396 ^SEK	+6,17 %		+4,76 %	-9,38 %

22.02.	AroCell AB (publ) meldet Ergebnis für das vierte Quartal bis zum 31. Dezember 2023	CI
22.02.	AroCell AB (publ) berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr	CI

AroCell - New patent approved on the US market	19.04.
Swedish Diagnostics Company AroCell Secures US Patent	18.04.
New patent approved on the US market	18.04.
AroCell Attends Three Prestigious Events: AACR, EAU Congress and COG Nordics	16.04.
AroCell publishes the Annual Report for 2023	15.04.
AroCell publishes the Annual Report for 2023	12.04.
The nomination committee's proposal for the board of AroCell for the Annual General Meeting 2024	12.03.
New Study: UBC Rapid can reduce the number of cystoscopies necessary in bladder cancer patients, enabling cost-effective follow-up	12.03.
Two Accepted Abstracts at AACR 2024 Explore Clinical Applications of TK1 Biomarker	11.03.
AroCell : Presentation at LabRoots 2024	04.03.
AroCell Q4 - Nearing positive operating cash flow	23.02.
AroCell AB (publ) Interim Report January 1st to December 31st, 2023	22.02.
AroCell AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22.02.
AroCell AB Reports Earnings Results for the Full Year Ended December 31, 2023	22.02.
AroCell Names CFO Goes on Parental Leave, Interim CFO Named	01.02.
Ellen Dittberner, AroCell's CFO, will be taking parental leave, and Lars Jakobsson will step in as the interim CFO.	01.02.
AroCell AB Announces Chief Financial Officer Changes	01.02.
AroCell has obtained regulatory approval for TUBEX TF in Ethiopia	26.01.
AroCell Wins Regulatory Nod for Typhoid Fever Rapid Test in Ethiopia	25.01.
AroCell has obtained regulatory approval for TUBEX® TF in Ethiopia	25.01.

Keine Ergebnisse zu dieser Suche